Market prioritization and rollout plan
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
“
Route mapped
Market Entry Plan
StatusRoute mapped
Our craft
Built around real regulatory affairs practice.
Service Detail
Expand into new markets with a practical filing route.
Leverage existing EU or US approvals and adapt the dossier intelligently for each country. PharmaRevix helps you prioritize markets, coordinate local representatives, and keep submissions moving.
You already have EU, UK, US, or India approvals
You want to enter Canada, ANZ, GCC, Switzerland, South Africa, Latam, or ROW markets
You need local representative coordination
You need one global tracker instead of scattered country updates
Deliverables
Practical outputs your team can use immediately.
Country dossier adaptation checklist
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Local representative and agent coordination plan
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Submission pack tracker by country
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Deficiency response support
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Lifecycle handoff plan after approval
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Workflow
A clear sequence from assessment to handoff.
01
Assess
Review existing approvals and core dossier strength
02
Plan
Prioritize markets by feasibility, timing, and business value
03
Execute
Adapt Modules 1-5 and local administrative content
04
Maintain
Coordinate filing, queries, and approval handoff
Proof Package
Every engagement leaves an evidence trail.
The work is designed for real review: authority questions, partner due diligence, quality audits, and internal leadership updates.
EU/US leverageLocal partnersSenior-led
Use existing approvals for accelerated international access
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Country-specific dossier adaptation for GCC, APAC, LATAM, and Africa
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Local representative coordination and submission management
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Response planning for country-specific questions
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Related Services
Connect this work with adjacent regulatory and safety needs.
Regulatory Strategy
Choose the right pathway before you spend on dossiers, studies, or local filings. PharmaRevix maps options, risks, data gaps, and authority expectations so teams can move with confidence.
Explore serviceMarketing Authorizations
PharmaRevix supports new applications, variations, renewals, annual reports, eCTD publishing, and MAH-related regulatory operations across key markets.
Explore serviceDossier Compilation & eCTD Publishing
PharmaRevix supports Module 1-5 compilation, baseline conversion, sequence management, validation, and submission-ready publishing across modern eCTD toolchains.
Explore serviceFAQ
Common questions about Global Expansion.
Short answers for teams deciding whether this is the right next step.
Ask us anythingYes. PharmaRevix can scope this as a standalone workstream or connect it with adjacent regulatory affairs, pharmacovigilance, QMS, and submission activities.
Yes. PharmaRevix can scope this as a standalone workstream or connect it with adjacent regulatory affairs, pharmacovigilance, QMS, and submission activities.
Yes. PharmaRevix can scope this as a standalone workstream or connect it with adjacent regulatory affairs, pharmacovigilance, QMS, and submission activities.
Free 30-minute consultation
Need global expansion support?
Talk with PharmaRevix about scope, timelines, and the cleanest next step for your market or safety obligation.